Neuroprotection in Aβ25-35 -Induced Alzheimer's Disease Model by Hawthorn Leaf Flavonoids
Clicks: 79
ID: 276375
2022
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
3.3
/100
11 views
11 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
It has been observed that increased accumulation of Aβ peptides in the brain triggers endogenous oxidative stress, neuroinflammation, and memory dysfunction in Alzheimer’s Disease (AD). Crataegus pinnatifida Bge. Commonly referred to as the Hawthorn leaf is a well-known traditional Chinese medicine. The plant is used for conditions such as hyperlipidemia, heart palpitations, forgetfulness, and tinnitus in mainstream medicinal practice, where the most important bioactive components consist of Hawthorn Leaf Flavonoids (HLF). Xu and associates showed that in a rat model given Aβ25-35 (bilateral hippocampus injection), the neuroprotective effects of HLF were significant. Oral doses of 50, 100, and 200 mg/kg for a time period of 30 days of HLF demonstrated significant attenuation of the damage to neurons alongside marked inhibition in memory deficits. Enhancement in the enzyme activities of superoxide dismutase and catalase, and glutathione content was seen. In contrast, HLF decreased the malondialdehyde content in the Aβ25-35 rat AD model and suppressed astrocytes’ activation, ameliorating neuroinflammation. HLF upregulated NQO-1, Nrf-2, and HO-1 protein expressions. These results demonstrated the potential of HLF as a potential AD therapeutic. Phytother Res (2022) DOI: 10.1002/ptr.7690.
| Reference Key |
Staff2022phytopharmacologicalNeuroprotection
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Editorial Staff; |
| Journal | Phytopharmacological Communications |
| Year | 2022 |
| DOI |
166
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.